A comparative analysis of semiannual versus annual rituximab maintenance in patients with refractory idiopathic inflammatory myopathies: a retrospective longitudinal real-world study. (PubMed, Rev Assoc Med Bras (1992)) - Oct 16, 2026 - "In this exploratory cohort, no statistically significant differences were detected between semiannual and annual rituximab maintenance regimens with respect to clinical outcomes, although numerically higher relapse rates were observed in the annual group. These findings suggest that extended rituximab intervals may be feasible in resource-limited settings, but further prospective studies are needed to confirm these observations."
Clinical • Journal • Real-world evidence • Retrospective data • Myositis
|
|
Fernando Henrique Carlos de Souza; Marlise Sítima Mendes Simões Faria; Renata Miossi; Rodrigo Lorenzetti Serrano; Samuel Katsuyuki Shinjo
|